TLL018

· Hangzhou Highlightll Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TLL018, covering 2024-12-27 to 2026-07-21. Get the full timeline:

Most recent: Clinical Trial Results: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis [Phase 2]